斯丹赛生物技术有限公司发布即将于美国基因与细胞治疗学会第23届年会上口头报告的两份CoupledCAR®实体瘤CAR-T技术摘要的详情
30 avr. 2020 18h55 HE
|
Innovative Cellular Therapeutics Co., Ltd.
马里兰州罗克维尔, May 01, 2020 (GLOBE NEWSWIRE) --...
Innovative Cellular Therapeutics Announces Details of Two Abstracts on its Novel CoupledCAR® Solid Tumor CAR-T Technology to be Presented Orally at the 23rd American Society of Gene & Cell Therapy Meeting
29 avr. 2020 08h00 HE
|
Innovative Cellular Therapeutics Co., Ltd.
ROCKVILLE, Md., April 29, 2020 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a clinical stage biotechnology company developing a comprehensive platform of chimeric antigen receptor...
斯丹赛生物技术有限公司宣布其用于治疗结直肠癌的新型CoupledCAR®技术的口头报告摘要被第23届美国基因与细胞治疗学会（ASGCT）年会收录
15 avr. 2020 12h16 HE
|
Innovative Cellular Therapeutics Co., Ltd.
马里兰州罗克维尔, April 16, 2020 (GLOBE NEWSWIRE) -- 马里兰州罗克维尔, April 14, 2020 (GLOBE NEWSWIRE) --...
斯丹賽生物技術有限公司宣佈其用於治療結直腸癌的新型CoupledCAR®技術的口頭報告摘要被第23屆美國基因與細胞治療學會（ASGCT）年會收錄
15 avr. 2020 12h16 HE
|
Innovative Cellular Therapeutics Co., Ltd.
馬里蘭州羅克維爾, April 16, 2020 (GLOBE NEWSWIRE) --...
Innovative Cellular Therapeutics Announces Acceptance of Abstract on its Novel CoupledCAR® Technology for Treating Colorectal Cancer for Oral Presentation at the 23rd American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
14 avr. 2020 08h00 HE
|
Innovative Cellular Therapeutics Co., Ltd.
ROCKVILLE, Md., April 14, 2020 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a clinical stage biotechnology company developing a comprehensive platform of chimeric antigen receptor...
Innovative Cellular Therapeutics Announces Data at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
08 mai 2019 08h00 HE
|
Innovative Cellular Therapeutics
ICT’s lead “armored” CAR-T program, ICTCAR014, demonstrated responses in two patients treated for refractory diffuse large B-cell lymphoma (DLBCL) in an investigator-sponsored clinical trial in China;...
斯丹赛生物技术有限公司 Innovative Cellular Therapeutics 宣佈圓滿完成與 FDA 的臨床試驗審請前（Pre-IND）會議
09 avr. 2019 21h00 HE
|
Innovative Cellular Therapeutics
中國上海和馬里蘭州羅克維爾, April 10, 2019 (GLOBE NEWSWIRE) -- 斯丹赛生物技术有限公司 (Innovative Cellu lar Therapeutics, ICT）是一間生物技術公司，主力開發治療癌症的細胞免疫療法。該公司在今天宣布與美國食品和藥物管理局（FDA）的臨床試驗審查前會議﹙研究性新藥﹚已圓滿結束。在會議上，FDA 就 ICT...
斯丹赛生物技术有限公司宣布圆满完成与FDA的新药临床试验申请前（Pre-IND）会议
09 avr. 2019 21h00 HE
|
Innovative Cellular Therapeutics
中国上海及美国马里兰州罗克维尔, April 10, 2019 (GLOBE NEWSWIRE) -- 斯丹赛生物技术有限公司（Innovative Cellular...
Innovative Cellular Therapeutics Announces Successful Completion of Pre-IND Meeting With FDA
09 avr. 2019 21h00 HE
|
Innovative Cellular Therapeutics
SHANGHAI, China and ROCKVILLE, Md., April 09, 2019 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a biotechnology company developing cellular immunotherapies for the treatment of...
Innovative Cellular Therapeutics Announces Successful Completion of Pre-IND Meeting With FDA
19 mars 2019 08h00 HE
|
Innovative Cellular Therapeutics
ROCKVILLE, Md., March 19, 2019 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a biotechnology company developing cellular immunotherapies for the treatment of cancer, today announced it...